People are far too sceptical of AE's investment imo.
AE's recent purchase of a further 11,000,000 securities actually occured on the day (16/5) the company released the update following the Rett Syndrome pre-IND meeting with FDA - they boosted their stake by 1% following the objective being achieved.
Who knows it may have been AE selling into the Pereis release of the botched trial but i highly doubt it, in my opinion it was retail investors taking positions based soley on the release of Pereis results & they didn't deliver tangible results without a control as many probably exopected.
Ann: CEO's address to AGM , page-31
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.41 |
Change
-0.580(2.90%) |
Mkt cap ! $2.505B | |||
| Open | High | Low | Value | Volume |
| $20.10 | $20.10 | $19.40 | $2.221M | 113.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 303 | $19.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.42 | 428 | 9 |
View Market Depth
| Last trade - 12.00pm 09/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |